Insider Buying: Dr. Martens (LON:DOCS) Insider Acquires £150.80 in Stock

Dr. Martens plc (LON:DOCS) insider Ije Nwokori acquired 232 shares of Dr. Martens stock in a transaction that occurred on Friday, September 11th. The shares were purchased at an average cost of GBX 65 per share, for a total transaction of £150.80.

Ije Nwokori also recently made the following trade(s):

• On Tuesday, August 11th, Ije Nwokori acquired 179 shares of Dr. Martens stock. The shares were purchased at an average price of GBX 84 per share, with a total value of £150.36.
• On Thursday, June 25th, Ije Nwokori bought 118,516 shares of Dr. Martens stock. The stock was purchased at an average price of GBX 72 per share, for a total transaction of £85,331.52.

Dr. Martens Trading Up 3.5%

Shares of LON DOCS traded up GBX 2.30 during midday trading on Wednesday, reaching GBX 67.30. 340,241 shares of the stock were exchanged, compared to its average volume of 6,982,917. The business has a 50-day simple moving average of GBX 76.82 and a two-hundred day simple moving average of GBX 70.51. The company has a market capitalization of £644.16 million, a price-to-earnings ratio of 28.04, a P/E/G ratio of 6.40 and a beta of 0.26. Dr. Martens plc has a 12 month low of GBX 59.15 and a 12 month high of GBX 100.87. The company has a debt-to-equity ratio of 108.85, a current ratio of 2.61 and a quick ratio of 1.13.

Wall Street Analyst Weigh In

Several research analysts have weighed in on DOCS shares. Berenberg Bank reduced their target price on Dr. Martens from GBX 114 to GBX 110 and set a “buy” rating on the stock in a report on Tuesday, May 19th. Royal Bank Of Canada reiterated a “sector perform” rating and set a GBX 100 price objective on shares of Dr. Martens in a report on Tuesday, June 2nd. Two research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of GBX 105.

About Dr. Martens

Dr. Martens is an iconic British footwear brand founded in Northamptonshire, England. Its first silhouette, the 1460 boot – named after the date it was produced – rolled off the production line on 1st April 1960. Originally chosen by workers for their air-cushioned comfort and durability, “Docs” or “DM’s” were later adopted by musicians and subcultural pioneers who took them from the street to the global stage.

Over six decades later, Dr. Martens operates in more than 60 countries and employs around 3,600 people.